Life Sciences

We create and invest in leading companies in therapeutics and medtech. If we can’t find a company solving an important problem, we create one ourselves — just like we did with Innovent, Denali, Beam, and Ultragenyx to name a few.

Life Sciences Portfolio

Spotlights Portfolio List People Impact

Portfolio List

Employs DragonFold technology for rapid protein/ligand co-folding to develop novel drugs.
Leveraging genomics data science to improve drug R&D and for population health.
Harnessing deep learning to accelerate pharmaceutical development.
Designing novel therapeutics against previously undruggable targets using experimental and computational biophysics.
Developing therapies that target aging at the cellular level.
The companies identified do not represent all the companies purchased, sold, or recommended for portfolios advised by F-Prime. A full list of investments made by funds managed by F-Prime is available below.

People

Alex Pasteur, Ph.D.
Alexander Munoz, M.D.
Amber Cai, Ph.D.
Anastasiya Sybirna, Ph.D.
Bobby Gaspar, M.D., Ph.D.
Brian Yordy, Ph.D.
Carlos Bustamante, Ph.D.
Carolyn Haley, M.S., CPA
Catherine Stehman-Breen
Chong Xu, Ph.D.
Clare Bernard
Connie Li
Garth Rapeport
Harlan Krumholz, M.D.
Jessica Alston, Ph.D.
John Shiver, Ph.D.
Ketan Patel, M.D.
Kevin Chu
Martin Taylor, Ph.D.
Mike Feng
Muzammil Mansuri, Ph.D.
Namandjé N. Bumpus, Ph.D.
Natasha Rodgers, MB BChir
Nicholas Haining, BM, BCh
Nihal Sinha, MB BChir
Nikhil Ananth
Raj Basak, Ph.D.
Robert Weisskoff, Ph.D.
Stacie Weninger, Ph.D.
Stephen Knight, M.D.
Thomas Beck, M.D.

Impact